Literature DB >> 20349796

Muscle metastasis of low-grade endometrial carcinoma seven years after diagnosis: a case report.

A Oaknin1, M P Barretina, I Morilla.   

Abstract

BACKGROUND: Early-stage low-grade endometrial carcinoma has an excellent prognosis. In few cases local relapse and/or distant metastases can occur. We report the muscle as an unusual site of metastasis. CASE: A 69-year-old woman underwent surgery for FIGO Stage IA, grade 1 endometrioid adenocarcinoma of the endometrium. After four years she had local relapse without response to chemoradiation, requiring pelvic exanteration. Three years later she was diagnosed with a deltoid muscle metastasis confirmed histologically and bone metastases. After failing hormone therapy, chemotherapy was administered. She died eight months after diagnosis of the bone and muscle metastases.
CONCLUSION: Low-risk endometrial carcinoma can behave like a high-risk group. Furthermore, this report describes, to our knowledge, the first case of endometrial carcinoma muscle metastasis.

Entities:  

Mesh:

Year:  2010        PMID: 20349796

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

1.  Orthopaedic case of the month: a 72-year-old man with a painful flexion contracture of the left thigh.

Authors:  Nathan L Cafferky; W James Malone; Thomas R Bowen
Journal:  Clin Orthop Relat Res       Date:  2012-09-08       Impact factor: 4.176

2.  Endometrioid endometrial carcinoma of no-specific-molecular-profile with multiple bone metastases and muscle involvement: Case report and review of the literature.

Authors:  Martin Heidinger; Mei Koh; Mario Panzenboeck; Thomas Lutz; Kirsten D Mertz; Hansjoerg Huemer; Marcus Vetter; Frey Tirri Brigitte
Journal:  Radiol Case Rep       Date:  2022-05-06

Review 3.  Bone metastases in endometrial cancer: report on 19 patients and review of the medical literature.

Authors:  Stefano Uccella; Jonathan M Morris; Jamie N Bakkum-Gamez; Gary L Keeney; Karl C Podratz; Andrea Mariani
Journal:  Gynecol Oncol       Date:  2013-05-15       Impact factor: 5.482

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.